Complication topics

Fistula

Fistula articles covering perianal disease, drainage, surgery, biologic treatment, and Crohn's disease complications. Complication context emphasizes risks, warning signs, treatment decisions, and follow-up care.

Page 1 of 2 · 49 articles

Comparative Effectiveness and Safety of Risankizumab vs Ustekinumab in Crohn's Disease: A Real-World Retrospective Cohort Study from Taiwan.
Journal of inflammation research

Comparative Effectiveness and Safety of Risankizumab vs Ustekinumab in Crohn's Disease: A Real-World Retrospective Cohort Study from Taiwan.

Comparative real-world data may help patients and clinicians weigh expected benefits and risks of risankizumab versus ustekinumab in Crohn’s disease, including effects on steroid-free remission and fistula healing.

Read Summary
Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study).
Inflammatory bowel diseases

Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study).

This Taiwanese multicenter real-world study reports high 52-week clinical response and remission rates, sustained one-year drug persistence, and meaningful fistula healing with ustekinumab in patients with Crohn’s...

Read Summary
Single-cell and spatial transcriptomics across populations with perianal fistulizing Crohn's disease shows pro-inflammatory CD4+ macrophage involvement in disease progression.
Cellular and molecular gastroenterology and hepatology

Single-cell and spatial transcriptomics across populations with perianal fistulizing Crohn's disease shows pro-inflammatory CD4+ macrophage involvement in disease progression.

The study points to a specific immune cell type (pro-inflammatory CD4+ macrophages) and altered cellular interactions in rectal tissue that are linked to perianal fistulizing Crohn's disease, which may help explain...

Read Summary
Use of an Oral Nutritional Supplement Containing Calcium Beta-Hydroxy-Beta-Methylbutyrate (CaHMB), L-arginine, and L-glutamine May Have Helped Avoid Surgery That Could Have Led to Short Bowel Syndrome: A Case Report.
Cureus

Use of an Oral Nutritional Supplement Containing Calcium Beta-Hydroxy-Beta-Methylbutyrate (CaHMB), L-arginine, and L-glutamine May Have Helped Avoid Surgery That Could Have Led to Short Bowel Syndrome: A Case Report.

Someone with Crohn’s disease and limited remaining small intestine may face high-risk surgical choices. This case report suggests a specialized oral supplement used with conservative care was associated with fistula...

Read Summary
Epigenetic modulation of stromal cell states underpins pathological tissue niches in Crohn's disease
nature.com

Epigenetic modulation of stromal cell states underpins pathological tissue niches in Crohn's disease

The paper maps distinct stromal cell states tied to inflamed versus fibrotic tissue niches in Crohn’s disease and shows that these states have different chromatin configurations and drug-modifiable properties — pointing...

Read Summary
Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation
ClinicalTrials.gov

Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation

People with an ileal pouch after UC/IBDU often struggle with fecal incontinence and reduced quality of life. This trial is testing a noninvasive device (Emsella chair) aimed at improving incontinence and patient-reported...

Read Summary
Long-term outcomes of laser therapy for perianal fistulising Crohn’s disease: a single-center retrospective cohort study
Developments and Experiments in Health and Medicine

Long-term outcomes of laser therapy for perianal fistulising Crohn’s disease: a single-center retrospective cohort study

Perianal fistulas in Crohn’s disease are hard to treat and preserving continence is important. Long-term data suggesting laser ablation can achieve sustained healing in some patients are relevant for treatment decisions.

Read Summary
A spatially organized immune-stromal program drives the fissure-to-fistula continuum in Crohn's disease.
Journal of Crohn's & colitis

A spatially organized immune-stromal program drives the fissure-to-fistula continuum in Crohn's disease.

The study maps cellular and molecular programs that drive transformation of fissures into fistulas in Crohn's disease, pointing to early remodeling processes and specific molecular pathways that could be targeted to...

Read Summary
The Impact of Fistulizing Disease, Treatment Modalities, and Clinical Activity on Health-Related Quality of Life in Crohn's Disease.
Digestive diseases and sciences

The Impact of Fistulizing Disease, Treatment Modalities, and Clinical Activity on Health-Related Quality of Life in Crohn's Disease.

The study indicates that active inflammation—measured by CDAI and PDAI—drives poorer quality of life in Crohn's disease more than the mere presence of fistulas. That shifts focus toward controlling inflammation to...

Read Summary
Efficacy of Ustekinumab for the treatment of perianal fistulizing Crohn's disease: a multicentre retrospective study.
Frontiers in medicine

Efficacy of Ustekinumab for the treatment of perianal fistulizing Crohn's disease: a multicentre retrospective study.

Perianal fistulizing Crohn's disease is difficult to treat and many patients have failed anti-TNF therapy. Evidence that ustekinumab achieves high clinical fistula response and remission rates in a real-world multicenter...

Read Summary
Single-Incision Laparoscopy-First Strategy in Crohn's Disease: Risk Factors for Conversion and Surgical Outcomes.
Annals of gastroenterological surgery

Single-Incision Laparoscopy-First Strategy in Crohn's Disease: Risk Factors for Conversion and Surgical Outcomes.

Findings are relevant because they describe outcomes and predictors of conversion for a minimally invasive surgery option (SILS) that some patients with Crohn's disease may be offered. Understanding risk factors can help...

Read Summary
Subcutaneous infliximab in the treatment of patients with perianal fistulizing Crohn's disease: current evidence and emerging roles.
Therapeutic advances in gastroenterology

Subcutaneous infliximab in the treatment of patients with perianal fistulizing Crohn's disease: current evidence and emerging roles.

Perianal fistulizing Crohn's disease is a disabling complication; a subcutaneous form of infliximab could lower treatment burden and expand options if its effectiveness and safety in this specific setting are confirmed.

Read Summary
A bile acid-GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis.
Gut microbes

A bile acid-GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis.

Fibrosis and stricturing are key problems in Crohn’s disease with limited therapies; this study identifies a microbiota–bile acid–GPBAR1 pathway by which a specific probiotic mix reduced inflammation and fibrosis in...

Read Summary
Perianal Crohn Disease in a Patient With Congenital Afibrinogenemia: A Multidisciplinary Therapeutic Management Challenge.
Cureus

Perianal Crohn Disease in a Patient With Congenital Afibrinogenemia: A Multidisciplinary Therapeutic Management Challenge.

People with IBD who also have bleeding disorders face special risks during endoscopy, surgery, and when using immunosuppressive drugs. This case shows that coordinated care and hemostatic support can allow diagnosis and...

Read Summary
Risk factors and fatigue in difficult-to-treat Crohn’s disease: A cross-sectional study of a Chinese cohort
World Journal of Gastroenterology

Risk factors and fatigue in difficult-to-treat Crohn’s disease: A cross-sectional study of a Chinese cohort

Identifies features associated with the new international definition of difficult‑to‑treat Crohn’s disease and links DTT status to greater mental fatigue. Biomarker differences (IL‑5, IL‑10) may point to distinct immune...

Read Summary